Therapeutic Strategies for Critical Limb Ischemia: Focus on Endogenous Cell Behavior Modulation

Abstract

Critical limb ischemia (CLI) represents the advanced stage of peripheral artery disease, with extremely high rate of amputation and mortality. Conventional treatments, including surgical revascularization and percutaneous interventions, are constrained by invasiveness and unsuitability for certain patients, highlighting the urgent need for novel therapeutic approaches. Emerging strategies that regulate endogenous cell behavior offer an effective, less traumatic alternative with wider applicability. This review systematically summarizes therapeutic approaches focused on key cell populations—endothelial cells, macrophages, muscle satellite cells, and pericytes—integral to the pathogenesis and repair mechanisms of CLI. We focus on molecular interventions aimed at regulating growth factors, transcription factors, inflammatory mediators, and metabolic pathways to promote endothelial tube formation, macrophage reprogramming, muscle regeneration, and pericyte recruitment, ultimately enhancing collateral circulation, improving the microenvironment, and drive tissue repair. Additionally, we discuss the integration of advanced bioengineering approaches—such as gene therapy, gasotransmitters, intelligent delivery systems, and functional biomaterials—which have significantly expanded the potential of CLI treatment. These engineered materials not only serve as carriers for targeted therapeutics but also actively modulate cellular behavior, providing sustained and localized intervention to optimize vascular repair and regeneration. Furthermore, the significance of intercellular crosstalk in the progression and treatment of CLI is emphasized, with great potential for synergistic enhancement of efficacy. By synthesizing the latest findings in CLI therapies based on cell behavior modulation, this review provides reference for innovative treatment paradigms and clinical applications.

Article information

Article type
Review Article
Submitted
07 Jun 2025
Accepted
27 Aug 2025
First published
29 Aug 2025

J. Mater. Chem. B, 2025, Accepted Manuscript

Therapeutic Strategies for Critical Limb Ischemia: Focus on Endogenous Cell Behavior Modulation

H. wang, X. Wang, C. Liu and C. Liu, J. Mater. Chem. B, 2025, Accepted Manuscript , DOI: 10.1039/D5TB01357G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements